Compagnie Financiere Tradition S.A. (0QL7)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 248.00 |
|---|---|
| 52-week range | 243.00 – 322.00 |
| Return, 1 month / 3 months | −3.1% / −19.2% |
| Return, 1 year / 3 years | −16.5% / – |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 24.8% |
| Worst drawdown (1 year) | -23.8% |
| Average daily value traded | 0.13M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Compagnie Financiere Tradition is a Swiss interdealer broker that stands between banks and other financial institutions when they trade. It arranges transactions in money market instruments, interest rate and currency products, bonds, equities and commodity-related contracts, earning fees for matching buyers and sellers. The company operates through offices in many countries and is based in Lausanne, Switzerland, serving wholesale financial markets rather than individual investors.
The shares are listed on the London Exchange in UK under the code 0QL7, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Compagnie Financiere Tradition S.A. (0QL7) trades on the London Exchange in UK. It last closed at GBP 248.00 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,658 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.5% and over the last three months it fell 19.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.6% | ||
| From 52-week high | -22.3% | ||
| Momentum | 23 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -19.2% | ||
| 6-month return | -11.7% | ||
| 12-month return, skipping the last month | -13.8% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.8% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.13M GBP | ||
| Zero-volume days | 5.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | −3.1% |
| 3 months | −19.2% |
| 6 months | −11.7% |
| 1 year | −16.5% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 258.44 / 280.40 |
|---|---|
| Golden / death cross (60 days) | Death, 26 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | GBX 0.0750 |
| 23 May 2025 | GBX 0.0675 |
| 23 May 2024 | GBX 0.0600 |
| 30 May 2023 | GBX 0.0556 |
| 27 May 2022 | GBX 0.0505 |
| 21 May 2021 | GBX 0.0507 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.